Name: UMIN ID:
Unique ID issued by UMIN | C000000153 |
---|---|
Receipt number | R000000222 |
Scientific Title | Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study) |
Date of disclosure of the study information | 2005/09/10 |
Last modified on | 2016/01/05 18:01:10 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/10 10:54:11 | ||
2 | Update | 2006/04/03 11:23:40 | Public title Public title Acronym Acronym |
|
3 | Update | 2006/04/03 11:46:08 | Genomic information |
|
4 | Update | 2006/04/03 12:22:08 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Organization Organization Division name Division name Address Institute Institute |
|
5 | Update | 2006/04/03 13:45:16 | Recruitment status Last follow-up date |
|
6 | Update | 2009/03/25 07:15:25 | Publication of results |
|
7 | Update | 2011/09/09 10:05:18 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2016/01/05 17:53:52 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results Results |
|
9 | Update | 2016/01/05 18:01:10 | Address Address Address Address Address1 |